Cargando…
Pilocarpine as a treatment option for dupilumab-related eye manifestations
Autores principales: | Roh, Won Seok, Lee, Joo Hee, Kim, Su Min, Byeon, Hyeong Ju, Park, Chang Ook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305317/ https://www.ncbi.nlm.nih.gov/pubmed/35875394 http://dx.doi.org/10.1016/j.jdin.2022.06.007 |
Ejemplares similares
-
Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis?
por: Kim, Su Min, et al.
Publicado: (2021) -
Eserine and Pilocarpine in the Treatment of Eye Disease
Publicado: (1878) -
Value of Jaborandi and Pilocarpine in Eye Diseases
Publicado: (1882) -
In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment
por: Jackson, Mitchell A., et al.
Publicado: (2022) -
Pilocarpine 1.25% for the treatment of presbyopia
por: Mansoori, Tarannum
Publicado: (2023)